[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341267-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341267-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","long-term-outcomes-and-prognosis-of-neuroendocrine-neoplasms-of-the-head-and-neck-a-cohort-from-a-single-institution","Long-term outcomes and prognosis of neuroendocrine neoplasms of the head and neck: a cohort from a single institution","","Retrospective clinical study evaluates long-term outcomes and prognosis for neuroendocrine neoplasms of the head and neck treated in a single institution. Ninety-three pathologically confirmed patients were reviewed from Nov 2000 to Nov 2021, with treatment strategies including chemotherapy plus radiotherapy, surgery plus post-operative radiotherapy, and primary surgery followed by salvage therapy. Median follow-up was 64.5 months; 5-year overall survival was 64.5% with progression-free survival at 51.6%. Radiotherapy showed improved local-regional control, while distant metastasis was the main failure pattern.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/long-term-outcomes-and-prognosis-of-neuroendocrine-neoplasms-of-the-head-and-neck-a-cohort-from-a-single-institution/341267/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/long-term-outcomes-and-prognosis-of-neuroendocrine-neoplasms-of-the-head-and-neck-a-cohort-from-a-single-institution/341267.png","ImageObject",300,407,{"name":42,"@type":43},"Violet","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of the study on neuroendocrine neoplasms of the head and neck?","Question",{"text":63,"@type":64},"To evaluate clinical features, treatment outcomes, and prognostic factors of neuroendocrine neoplasms of the head and neck treated at a single institution.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which patient treatments were compared in the cohort?",{"text":68,"@type":64},"Chemotherapy combined with radiotherapy (C + RT), surgery followed by post-operative radiotherapy (S + RT), and primary surgery plus salvage therapy (S + Sa).",{"name":70,"@type":61,"acceptedAnswer":71},"How did radiotherapy affect outcomes in local-regional control?",{"text":72,"@type":64},"Radiotherapy improved local-regional control, with higher 5-year loco-regional relapse-free survival in groups receiving radiotherapy, especially across different clinical stages.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341267,1790169717,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Journal of Cancer Research and Clinical Oncology (2024) 150:288  \n[https://doi.org/10.1007/s00432-024-05726-1](https://doi.org/10.1007/s00432-024-05726-1)  \nLong‑term outcomes and prognosis of neuroendocrine neoplasms of the head and neck: a cohort from a single institution  \nXinqi Shi1 · Xiaodong Huang1 · Kai Wang1 · Yuan Qu1 · Xuesong Chen1 · Runye Wu1 · Ye Zhang1 · Jianghu Zhang1 · Jingwei Luo1 · Jingbo Wang1 · Junlin Yi1,2  \nReceived: 5 March 2024 / Accepted: 25 March 2024 / Published online: 4 June 2024 © The Author(s) 2024  \nAbstract  \nBackground Neuroendocrine neoplasm is a rare cancer of head and neck. This study aimed to evaluate clinical features, treatment outcomes, and prognostic factors of neuroendocrine neoplasm of head and neck treated at a single institution. Methods Between Nov 2000 and Nov 2021, ninety-three patients diagnosed with neuroendocrine neoplasms of head and neck treated at our institution were reviewed retrospectively. The initial treatments included chemotherapy (induction, adjuvant, or concurrent) combined with radiotherapy in 40 patients (C + RT group), surgery followed by post-operative RT in 34 (S + RT group), and surgery plus salvage therapy in 19 patients (S + Sa group) .  \nResults The median follow-up time was 64.5 months. 5-year overall survival rate (OS), progression-free survival rate (PFS), loco-regional relapse-free survival free rate (LRRFS) and distant metastasis-free survival rate (DMFS) were 64.5%, 51.6%, 66.6%, and 62.1%, respectively. For stage I–II, the 5-year LRRFS for patients’ treatment regimen with or without radiotherapy (C + RT and S + RT groups versus S + Sa group) was 75.0% versus 12.7%(p = 0.015) while for stage III–IV, the 5-year LRRFS was 77.8% versus 50.0%(p = 0.006). The 5-year DMFS values for patients with or without systemic therapy (C + RT group versus S + RT or S + Sa) were 71.2% and 51.5%(p = 0.075) . 44 patients (47.3%) experienced treatment failure and distant metastasis was the main failure pattern.  \nConclusions Radiotherapy improved local–regional control and played an important role in the management of HNNENs. The optimal treatment regimen for HNNENs remains the combination of local and systemic treatments.  \nKeywords Neuroendocrine neoplasm of the head and neck · Survival outcome · Treatment regimens · Radiotherapy  \nIntroduction  \nNeuroendocrine neoplasm is a rare and heterogeneous tumor type (Rindi et al. 2022), comprising about 2% of all malignancies, with the most common site of lung (Oronsky et al.  \n* Jingbo Wang [wangjingbo201001@163.com](wangjingbo201001@163.com)  \n* Junlin Yi [yijunlin1969@163.com](yijunlin1969@163.com)  \n1 Department of Radiation Oncology, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China  \n2 Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Hebei Cancer Hospital, Chinese Academy of Medical Sciences (CAMS), Langfang, China  \n2017 ; Rekhtman 2022). Primary neuroendocrine neoplasms of the head and neck (HNNENs) are rare, accounting for only 0.3% of all head and neck cancers (Ohmoto et al. 2021 ; Rindi et al. 2022) . Due to the low incidence, studies describing features and management of HNNEN remain limited.  \nThe World Health Organization (WHO) 2022 Classification of head and neck tumors divides HNNENs into well-differentiated neuroendocrine tumors of head and neck (HNNETs) and poor-differentiated neuroendocrine carcinomas of the head and neck (HNNECs) (Mete and Wenig 2022) . HNNETs are generally graded as G1, G2, and G3 based on proliferation, and HNNECs are sub-classified as small or large cell types according to cell morphology (Mete and Wenig 2022) . Moreover, the widely accepted classification, which divided HNNETs into typical carcinoids and atypical carcinoids, is previously used.  \nTreatment modalities, including surgery, radiotherapy, chemotherapy, ","cbCail9TBuKqJ4Rt","https://ap.wps.com/l/cbCail9TBuKqJ4Rt","pdf",829469,"English","# Abstract\n# Introduction\n# Methods\n## Patient data\n## Treatment","[{\"question\":\"What was the purpose of the study on neuroendocrine neoplasms of the head and neck?\",\"answer\":\"To evaluate clinical features, treatment outcomes, and prognostic factors of neuroendocrine neoplasms of the head and neck treated at a single institution.\"},{\"question\":\"Which patient treatments were compared in the cohort?\",\"answer\":\"Chemotherapy combined with radiotherapy (C + RT), surgery followed by post-operative radiotherapy (S + RT), and primary surgery plus salvage therapy (S + Sa).\"},{\"question\":\"How did radiotherapy affect outcomes in local-regional control?\",\"answer\":\"Radiotherapy improved local-regional control, with higher 5-year loco-regional relapse-free survival in groups receiving radiotherapy, especially across different clinical stages.\"}]","Long-term outcomes and prognosis of neuroendocrine neoplasms of the head and neck: a cohort from a single institution | PDF",1790041225,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd22132627df7a25d39bac25ffc03ea2.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f581f573d412482682cb1b1092eb7c9.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ba0a01664301af0762709107c6ba7a9.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aece259764a35d9e1ab58ca118834ce2.webp",980,1301]